​Advanced Device Therapy for Epilepsy

Cadence Neuroscience is developing a next generation implantable device therapy for epilepsy.  The therapy, pioneered by researchers at Mayo Clinic over the past decade, uses advanced methods to provide individualized treatment for each patient.  Our core technology includes a specialized neuromodulation platform that enables these methods.  Cadence is currently engaged in the engineering and testing of the platform, and preparing for additional clinical evaluations.